Search - tctmd.com

Displaying 121 - 140 of 662

Sort: Relevancy | Date

News Conference News TCT 2023

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

Michael O'Riordan

October 25, 2023

Presentation TCT 2023

TCT 473: Performance of MIRACLE2 score by Ethnicity and Biological Sex - A post hoc analysis of MIRACLE2 Study

Presenter: Lap Tin Lam

October 25, 2023

Presentation TCT 2023

TCT 461: Suboptimal Lipid Lowering Treatment After Complex PCI in Contemporary Practice

Presenter: Denise Peeters

October 25, 2023

Presentation TCT 2023

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

Presenter: Mick Renkens

October 25, 2023

Presentation TCT 2023

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

Presenter: Jung-Hee Lee

October 25, 2023

Presentation TCT 2023

TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

Presenter: Ji-Yong Jang

October 25, 2023

TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing PCI

Presentation TCT 2023

TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data…

Presenter: Young-Hoon Seo

October 25, 2023

Presentation TCT 2023

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

Presenter: Michael Bloch

October 25, 2023

Presentation TCT 2023

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

Presenter: Felix Mahfoud

October 25, 2023

Presentation TCT 2023

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

Presenter: Ron miller

October 25, 2023

Presentation TCT 2023

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

Presenter: Tomasz Skowerski

October 25, 2023

News Conference News TCT 2023

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

Yael L. Maxwell

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

Presenter: NULL

October 25, 2023

Presentation TCT 2023

A High Standard of Clinical Evidence: Recent Key Milestones

Presenter: NULL

October 25, 2023

Presentation TCT 2023

TCT 628: The Impact of Long-term Exposure to Air Pollution on Plaque Characteristics Assessed by Intravascular Optical Coherence Tomography

Presenter: Juhwan Lee

October 25, 2023

Presentation TCT 2023

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

Presenter: Karlis Trusinskis

October 25, 2023

Presentation TCT 2023

TCT 379: Impact of the Residual Lipid Burden on the Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention

Presenter: Woohyeun Kim

October 25, 2023

Presentation TCT 2023

TCT 252: NIRS-IVUS assessment of OCT-derived Healed Coronary Plaques

Presenter: Kosei Terada

October 25, 2023

Advertisement

Does Thrombolysis Have a Role in a Primary-PCI World? Experts Hash It Out

TCT 473: Performance of MIRACLE2 score by Ethnicity and Biological Sex - A post hoc analysis of MIRACLE2 Study

TCT 461: Suboptimal Lipid Lowering Treatment After Complex PCI in Contemporary Practice

TCT 271: Characterizing pathophysiological patterns of coronary artery disease among Individuals with Elevated Lipoprotein(a).

TCT 249: Remnant Cholesterol as a Residual Risk in Patients with Atherosclerotic Cardiovascular Disease under Moderate-intensity Statin with Ezetimibe Combination Therapy or High-intensity Statin Monotherapy

TCT 160: Comparative Effectiveness of Moderate-intensity Statin with Ezetimibe Combination Therapy Versus High-intensity Statin Monotherapy After Percutaneous Coronary Intervention: A Nationwide Cohort Study

TCT 50: Statin and Ezetimibe Combination Therapy Versus Statin Monotherapy for Cardiovascular Outcomes Among Patients Undergoing Percutaneous Coronary Intervention: A Nationwide, Retrospective, Population-based Study Using National Health Insurance Data…

TCT 325: Changes in Blood Pressure after Crossover to Ultrasound Renal Denervation: Patient-Level Pooled Analysis of the Sham-Controlled RADIANCE II, RADIANCE-HTN SOLO and RADIANCE-HTN TRIO Trials

TCT 267: Pooled, 12-month Blood Pressure Reductions Using the Symplicity Spyral Radiofrequency Renal Denervation Catheter

TCT 244: Impact of Online Educational Series on Interventional Innovations in Blood Pressure Control

TCT 3: Renal Artery Denervation Combined with Pulmonary Vein Isolation in Patients with Heart Failure and Atrial Fibrillation - Pilot Study

In ACS, Ticagrelor Only After < 1 Month DAPT Beats Continuing Aspirin: T-PASS

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Hypertension Care Pathway with uRDN: Experiences from Clinical Trials

A High Standard of Clinical Evidence: Recent Key Milestones

TCT 628: The Impact of Long-term Exposure to Air Pollution on Plaque Characteristics Assessed by Intravascular Optical Coherence Tomography

TCT 555: NIRS-Detected Lipid-Rich Plaques are Highly Responsive to Novel Escalated LDL-C Reduction Therapy

TCT 379: Impact of the Residual Lipid Burden on the Clinical and Angiographic Outcomes After Percutaneous Coronary Intervention

TCT 252: NIRS-IVUS assessment of OCT-derived Healed Coronary Plaques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content